Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 436.6M | 408.3M | 392.0M | 366.6M |
| Cost of revenue | 109.7M | 98.5M | 92.6M | 81.8M |
| Gross profit | 327.0M | 309.8M | 299.4M | 284.8M |
| Operating expense | ||||
| Research & development | 114.7M | 98.1M | 102.5M | 94.5M |
| Selling general and admin | 269.6M | 257.1M | 226.5M | 216.5M |
| Other operating expenses | — | — | — | — |
| Operating income | -57.3M | -45.4M | -29.6M | -26.2M |
| Non operating interest income | ||||
| Income | 21.7M | 18.2M | 18.7M | 19.2M |
| Expense | 1.3M | 1.2M | 1.2M | 1.2M |
| Other income expense | -3.3M | -3.0M | 2.8M | -2.6M |
| Pretax income | -40.3M | -31.3M | -9.2M | -10.9M |
| Tax provision | 2.7M | 1.4M | 1.7M | 2.1M |
| Net income | -43.0M | -32.8M | -11.0M | -13.1M |
| Basic EPS | — | -0.1 | 0.0 | 0.0 |
| Diluted EPS | — | -0.1 | 0.0 | 0.0 |
| Basic average shares | — | 294.7M | 293.2M | 291.8M |
| Diluted average shares | — | 294.7M | 293.2M | 291.8M |
| EBITDA | -242.1K | 5.9M | 22.9M | 17.3M |
| Net income from continuing op. | -43.0M | -32.8M | -11.0M | -13.1M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |